Market by Display, Technology, Type, End-user, and Country Outlook | Forecast 2022-2028
The report by Triton Market Research indicates that the cardiovascular ultrasound market in the Middle East and Africa would progress with a CAGR of 6.31% in the forecast years from 2022 to 2028.
The
countries scrutinized in this market include:
• The
United Arab Emirates
• South
Africa
• Turkey
• Saudi
Arabia
• Rest
of Middle East & Africa
The United Arab Emirates is expected to observe
the fastest growth in this region. The rising demand for non-invasive
diagnostic procedures, coupled with the implementation of numerous
cardiovascular research activities and the rise in healthcare spending, are the
key factors driving the growth of the cardiovascular ultrasound market in the
Middle East and Africa region.
The UAE has a high prevalence
of risk factors for cardiovascular disease (CVD). Further, at 40%, the
percentage of CVD deaths among total deaths, in the population is also
significantly high. With the high disease burden as well as treatment costs,
primary prevention is considered the most beneficial and cost-effective
intervention strategy for CVD.
Clinical guidelines thus recommend incorporating
risk assessment tools into routine clinical practice for diseases concerning
heart health. This helps in accurately identifying and treating individuals at
high risk of developing these conditions. This, as a result, has driven the
demand for echocardiography systems in the country.
Non-communicable diseases are the second major
cause of mortality in sub-Saharan Africa, accounting for approximately 2.6
million (or ~ 35%) of total deaths. The overall number of deaths due to
cardiovascular diseases in this region has increased by over 50% in the last
thirty years.
In South Africa, the three most common causes of
CVD-related deaths are ischemic heart disease, hypertensive heart disease, and
stroke. The growing disease prevalence has necessitated timely diagnosis,
which, in turn, has bolstered the demand for cardiovascular ultrasound systems
in the country.
Transesophageal echocardiography is a type of
test that provides a detailed image of the heart. High-frequency sound waves
are used in this process, which create a detailed image showing the heart and
arteries. During the procedure, an echo transducer or probe, which is a thin
tube, is attached to the patient. It passes through the mouth, down from the
throat, to reach the esophagus in order to generate sound waves.
The
report assesses the market according to type, end-user, display, and
technology. Here, the
type segment comprises transesophageal echocardiography, fetal
echocardiography, transthoracic echocardiography, and other types.
Dawei
Medical, Lanmage, Siemens Healthineers, Philips Healthcare, Esaote S.p.A.,
Leltek Inc, Telemed Ultrasound Medical Systems, and Samsung Medison Co Ltd are
some of the notable companies in the cardiovascular ultrasound market.
Philips Healthcare is engaged in developing and
distributing diagnostic imaging systems, healthcare IT solutions, cardiac
devices, and patient monitoring systems. EPIQ CVx and Affiniti CVx are two key
products in the company’s product portfolio for cardiovascular healthcare. With
a vast industry experience of over 100 years, Philips Healthcare has a business
presence across several regions, including the Middle East and Africa.
Key deliverables of the report:
● Market CAGR during the forecasting years 2022-2028
● Detailed data highlighting key insights, industry components, and market strategies
● Comprehensive information and estimation of the cardiovascular ultrasound market revenue growth in the Middle East and Africa and its influence on the parent market
● In-depth study of forthcoming trends in consumer behavioral patterns
● A meticulous analysis of the competitive landscape, vendor scorecard, and Porter’s Five Forces Model
●
A wide-ranging study of factors that will challenge the Middle
East and Africa cardiovascular ultrasound market’s growth during the upcoming
years
Want to get specific insights? Our team of
analysts can customize this report based on your preferences. Connect with us here.
1. MIDDLE
EAST AND AFRICA CARDIOVASCULAR ULTRASOUND MARKET – SUMMARY
2. INDUSTRY
OUTLOOK
2.1. IMPACT
OF COVID-19 ON THE CARDIOVASCULAR ULTRASOUND MARKET
2.2. KEY
INSIGHTS
2.2.1. EMERGENCE
OF ARTIFICIAL INTELLIGENCE (AI)
2.2.2. STRAIN
IMAGING HAS SEEN A GRADUAL INCREASE
2.3. PORTER’S
FIVE FORCES ANALYSIS
2.3.1. THREAT
OF NEW ENTRANTS
2.3.2. THREAT
OF SUBSTITUTES
2.3.3. BARGAINING
POWER OF BUYERS
2.3.4. BARGAINING
POWER OF SUPPLIERS
2.3.5. THREAT
OF COMPETITIVE RIVALRY
2.4. KEY
IMPACT ANALYSIS
2.4.1. QUALITY
2.4.2. DURABILITY
2.4.3. PRICE
2.4.4. TECHNOLOGY
2.5. MARKET
ATTRACTIVENESS INDEX
2.6. VENDOR
SCORECARD
2.7. INDUSTRY
COMPONENTS
2.8. KEY
MARKET STRATEGIES
2.8.1. PRODUCT
LAUNCHES
2.8.2. ALLIANCES
2.9. MARKET
DRIVERS
2.9.1. INCREASE
IN CARDIOVASCULAR DISEASE CASES
2.9.2. ADVANCEMENTS
IN TECHNOLOGY
2.10. MARKET
CHALLENGES
2.10.1. LACK
OF AWARENESS AMONG PATIENTS
2.10.2. NEED
TO ABIDE BY STRINGENT REGULATIONS
2.11. MARKET
OPPORTUNITIES
2.11.1. RAPID
EXPANSION OF POINT-OF-CARE ULTRASOUND (POCUS)
2.11.2. RAPID
GROWTH OF FETAL ECHOCARDIOGRAPHY
3. MIDDLE
EAST AND AFRICA CARDIOVASCULAR ULTRASOUND MARKET OUTLOOK – BY DISPLAY
3.1. BLACK
AND WHITE
3.2. COLORED
4. MIDDLE
EAST AND AFRICA CARDIOVASCULAR ULTRASOUND MARKET OUTLOOK – BY TECHNOLOGY
4.1. 2D
4.2. 3D/4D
4.3. DOPPLER
5. MIDDLE
EAST AND AFRICA CARDIOVASCULAR ULTRASOUND MARKET OUTLOOK – BY TYPE
5.1. TRANSTHORACIC
ECHOCARDIOGRAPHY
5.2. FETAL
ECHOCARDIOGRAPHY
5.3. TRANSESOPHAGEAL
ECHOCARDIOGRAPHY
5.4. OTHER
TYPES
6. MIDDLE
EAST AND AFRICA CARDIOVASCULAR ULTRASOUND MARKET OUTLOOK – BY END-USER
6.1. HOSPITALS
6.2. DIAGNOSTIC
CENTERS
6.3. AMBULATORY
CARE CENTERS
6.4. OTHER
END-USERS
7. MIDDLE
EAST AND AFRICA CARDIOVASCULAR ULTRASOUND MARKET – COUNTRY OUTLOOK
7.1. UNITED
ARAB EMIRATES
7.2. SAUDI
ARABIA
7.3. TURKEY
7.4. SOUTH
AFRICA
7.5. REST
OF MIDDLE EAST & AFRICA
8. COMPETITIVE
LANDSCAPE
8.1. GE
HEALTHCARE
8.2. PHILIPS
HEALTHCARE
8.3. SIEMENS
HEALTHINEERS
8.4. CANON MEDICAL
CORP
8.5. FUJIFILM
HOLDINGS CORPORATION
8.6. SAMSUNG
MEDISON CO LTD
8.7. ESAOTE
S.P.A.
8.8. MINDRAY
MEDICAL INTERNATIONAL LIMITED
8.9. VIATOM
TECHNOLOGY CO
8.10. LANMAGE
8.11. DAWEI
MEDICAL
8.12. ZONCARE
8.13. LELTEK
INC
8.14. TELEMED
ULTRASOUND MEDICAL SYSTEMS
8.15. CLARIUS
9. RESEARCH
METHODOLOGY & SCOPE
9.1. RESEARCH
SCOPE & DELIVERABLES
9.2. SOURCES
OF DATA
9.3. RESEARCH
METHODOLOGY
TABLE 1: MIDDLE EAST AND
AFRICA CARDIOVASCULAR ULTRASOUND MARKET, BY COUNTRY OUTLOOK, 2022-2028 (IN $
MILLION)
TABLE 2: VENDOR SCORECARD
TABLE 3: LIST OF PRODUCT
LAUNCHES
TABLE 4: LIST OF ALLIANCES
TABLE 5: MIDDLE EAST &
AFRICA CARDIOVASCULAR ULTRASOUND MARKET, BY COUNTRY OUTLOOK, 2022-2028 (IN $
MILLION)
TABLE 6: MIDDLE EAST &
AFRICA CARDIOVASCULAR ULTRASOUND MARKET, BY DISPLAY, 2022-2028 (IN $ MILLION)
TABLE 7: MIDDLE EAST &
AFRICA CARDIOVASCULAR ULTRASOUND MARKET, BY TECHNOLOGY, 2022-2028 (IN $
MILLION)
TABLE 8: MIDDLE EAST &
AFRICA CARDIOVASCULAR ULTRASOUND MARKET, BY TYPE, 2022-2028 (IN $ MILLION)
TABLE 9: MIDDLE EAST &
AFRICA CARDIOVASCULAR ULTRASOUND MARKET, BY END-USER, 2022-2028 (IN $ MILLION)
FIGURE 1: KEY BUYING IMPACT
ANALYSIS
FIGURE 2: MARKET
ATTRACTIVENESS INDEX
FIGURE 3: INDUSTRY COMPONENTS
FIGURE 4: MIDDLE EAST AND
AFRICA CARDIOVASCULAR ULTRASOUND MARKET, BY DISPLAY, 2021 & 2028 (IN %)
FIGURE 5: MIDDLE EAST AND
AFRICA CARDIOVASCULAR ULTRASOUND MARKET, BY BLACK AND WHITE, 2022-2028 (IN $
MILLION)
FIGURE 6: MIDDLE EAST AND
AFRICA CARDIOVASCULAR ULTRASOUND MARKET, BY COLORED, 2022-2028 (IN $ MILLION)
FIGURE 7: MIDDLE EAST AND
AFRICA CARDIOVASCULAR ULTRASOUND MARKET, BY TECHNOLOGY, 2021 & 2028 (IN %)
FIGURE 8: MIDDLE EAST AND
AFRICA CARDIOVASCULAR ULTRASOUND MARKET, BY 2D, 2022-2028 (IN $ MILLION)
FIGURE 9: MIDDLE EAST AND
AFRICA CARDIOVASCULAR ULTRASOUND MARKET, BY 3D/4D, 2022-2028 (IN $ MILLION)
FIGURE 10: MIDDLE EAST AND
AFRICA CARDIOVASCULAR ULTRASOUND MARKET, BY DOPPLER, 2022-2028 (IN $ MILLION)
FIGURE 11: MIDDLE EAST AND
AFRICA CARDIOVASCULAR ULTRASOUND MARKET, BY TYPE, 2021 & 2028 (IN %)
FIGURE 12: MIDDLE EAST AND
AFRICA CARDIOVASCULAR ULTRASOUND MARKET, BY TRANSTHORACIC ECHOCARDIOGRAPHY,
2022-2028 (IN $ MILLION)
FIGURE 13: MIDDLE EAST AND
AFRICA CARDIOVASCULAR ULTRASOUND MARKET, BY FETAL ECHOCARDIOGRAPHY, 2022-2028
(IN $ MILLION)
FIGURE 14: MIDDLE EAST AND
AFRICA CARDIOVASCULAR ULTRASOUND MARKET, BY TRANSESOPHAGEAL ECHOCARDIOGRAPHY,
2022-2028 (IN $ MILLION)
FIGURE 15: MIDDLE EAST AND
AFRICA CARDIOVASCULAR ULTRASOUND MARKET, BY OTHER TYPES, 2022-2028 (IN $
MILLION)
FIGURE 16: MIDDLE EAST AND
AFRICA CARDIOVASCULAR ULTRASOUND MARKET, BY END-USER, 2021 & 2028 (IN %)
FIGURE 17: MIDDLE EAST AND
AFRICA CARDIOVASCULAR ULTRASOUND MARKET, BY HOSPITALS, 2022-2028 (IN $ MILLION)
FIGURE 18: MIDDLE EAST AND
AFRICA CARDIOVASCULAR ULTRASOUND MARKET, BY DIAGNOSTIC CENTERS, 2022-2028 (IN $
MILLION)
FIGURE 19: MIDDLE EAST AND
AFRICA CARDIOVASCULAR ULTRASOUND MARKET, BY AMBULATORY CARE CENTERS, 2022-2028
(IN $ MILLION)
FIGURE 20: MIDDLE EAST AND
AFRICA CARDIOVASCULAR ULTRASOUND MARKET, BY OTHER END-USERS, 2022-2028 (IN $
MILLION)
FIGURE 21: MIDDLE EAST AND
AFRICA CARDIOVASCULAR ULTRASOUND MARKET, COUNTRY OUTLOOK, 2021 & 2028 (IN
%)
FIGURE 22: UNITED ARAB
EMIRATES CARDIOVASCULAR ULTRASOUND MARKET 2022-2028 (IN $ MILLION)
FIGURE 23: SAUDI ARABIA
CARDIOVASCULAR ULTRASOUND MARKET 2022-2028 (IN $ MILLION)
FIGURE 24: TURKEY CARDIOVASCULAR
ULTRASOUND MARKET 2022-2028 (IN $ MILLION)
FIGURE 25: SOUTH AFRICA
CARDIOVASCULAR ULTRASOUND MARKET 2022-2028 (IN $ MILLION)
FIGURE 26: REST OF MIDDLE EAST
& AFRICA CARDIOVASCULAR ULTRASOUND MARKET 2022-2028 (IN $ MILLION)